Zhejiang King-New Pharmaceutical Co., Ltd. Rules of Procedure for Board of Directors Meetings
(Reviewed and approved by the third meeting of the Ninth Board of Directors on January 12, 2026, pending approval by the first Extraordinary General Meeting of Shareholders in 2026) (Draft) (Applicable After H Share Listing)
Chapter 1 General Principles
Article 1 To standardize and improve the procedures for board meetings and decision-making of Zhejiang King-New Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "this Company"), to enable directors and the board to effectively perform their duties, enhance the democratic and scientific nature of the Company's decision-making, and adapt to the needs of establishing a modern enterprise system, these Rules are hereby formulated. To standardize the operating procedures of the Board of Directors and fully leverage its role in business decision-making, these Rules are hereby formulated in accordance with the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Stock Listing Rules of the Shenzhen Stock Exchange," "Corporate Governance Guidelines for Listed Companies," "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Standardized Operation of Main Board Listed Companies," "Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited," (hereinafter referred to as the "Hong Kong Stock Exchange Listing Rules"), and other relevant laws, regulations, normative documents, and the "Articles of Association."